ArticleBMC public health2026
Comparing the predictive accuracy of life's essential 8 and life's crucial 9 scores for all-cause mortality in COPD patients among US adults: a prospective cohort study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLife’s Essential 8 (LE8) represents an established score for quantifying cardiovascular health (CVH). Life’s Crucial 9 (LC9) is a newly proposed metric that integrates psychological health with LE8. The prognostic significance of these scores concerning all-cause mortality risk in COPD patients remains unclear.
methodsWe analyzed data from NHANES 2005–2018 to examine the relationship between CVH (quantified by LC9 and LE8 scores) and all-cause mortality among adults with COPD. Cox proportional hazards regression was applied, and additional analyses were conducted to assess robustness.
resultsAmong 1,757 participants (380 deaths, 21.63%) over a 72-month median follow-up, the highest LC9 score quartile was associated with a significantly lower mortality risk when compared to the lowest quartile (HR = 0.36, 95% CI: 0.22–0.59). A similar inverse association was observed for the LE8 score. LC9 consistently demonstrated marginally higher predictive accuracy than LE8 across analyses.
conclusionHigher CVH levels defined by either LC9 or LE8 were strongly associated with reduced all-cause mortality in COPD patients. The slightly superior performance of LC9 highlights the added value of psychological health inclusion into cardiovascular health assessment to enhance mortality risk stratification and guide comprehensive COPD management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.